GelMEDIX is a biotechnology company developing regenerative medicines committed to combatting vision loss with our groundbreaking biomaterials platform
GelMEDIX is a biotechnology company developing regenerative medicines committed to combatting vision loss with our groundbreaking biomaterials platform. Our lead program is focused on preserving vision for patients suffering from Geographic Atrophy (GA), the leading cause of blindness in adults over 60. With no approved therapies to maintain vision, patients continue to lose their independence. Regenerative medicine, specifically retinal pigment epithelial (RPE) cell therapy, has the potentialto